NEW BRUNSWICK, N.J.,
July 14, 2021 /PRNewswire/ -- Johnson
& Johnson Consumer Inc. (JJCI) (NYSE: JNJ) is voluntarily
recalling all lots of five NEUTROGENA® and
AVEENO® aerosol sunscreen product lines to the consumer
level. Internal testing identified low levels of benzene in some
samples of the products. Consumers should stop using the affected
products and follow the instructions set forth below.
The only sunscreen products impacted are aerosol products,
specifically:
- NEUTROGENA® Beach Defense® aerosol
sunscreen,
- NEUTROGENA® Cool Dry Sport aerosol sunscreen,
- NEUTROGENA® Invisible Daily™ defense aerosol
sunscreen,
- NEUTROGENA® Ultra Sheer® aerosol
sunscreen, and
- AVEENO® Protect + Refresh aerosol sunscreen.
Product images and lot information is available on
www.Neutrogena.com and www.Aveeno.com.
Benzene is classified as a human carcinogen, a substance that
could potentially cause cancer depending on the level and extent of
exposure. Benzene is ubiquitous in the environment. Humans around
the world have daily exposures indoors and outdoors from multiple
sources. Benzene can be absorbed, to varying degrees, by
inhalation, through the skin, and orally. Based on exposure
modeling and the Environmental Protection Agency's (EPA) framework,
daily exposure to benzene in these aerosol sunscreen products at
the levels detected in our testing would not be expected to cause
adverse health consequences. Out of an abundance of caution, we are
recalling all lots of these specific aerosol sunscreen
products.
While benzene is not an ingredient in any of our sunscreen
products, it was detected in some samples of the impacted aerosol
sunscreen finished products. We are investigating the cause of this
issue, which is limited to certain aerosol sunscreen products.
Sunscreen use is critical to public health. Melanoma incidences
continue to increase worldwide, and the majority of cases are
caused by excessive sun exposure. It is important that people
everywhere continue to take appropriate sun protection measures,
including the continued use of alternative sunscreen.
The recalled sunscreen products are packaged in aerosol cans.
The products were distributed nationwide through a variety of
retail channels.
Consumers should stop using these specific products and
appropriately discard them. Consumers may contact the JJCI Consumer
Care Center 24/7 with questions or to request a refund by
calling 1-800-361-8068. Consumers should contact their
physician or healthcare provider if they have any questions,
concerns or have experienced any problems related to using these
aerosol sunscreen products. JJCI is also notifying its distributors
and retailers by letter and is arranging for returns of all
recalled products.
Adverse reactions or quality problems experienced with the use
of this product may be reported to the FDA's MedWatch Adverse Event
Reporting program either online, by regular mail or by fax.
- Complete and submit the report Online:
www.fda.gov/medwatch/report.htm
- Regular Mail or Fax: Download form
www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request
a reporting form, then complete and return to the address on the
pre-addressed form, or submit by fax to 1-800-FDA-0178.
This recall is being conducted with the knowledge of the U.S.
Food and Drug Administration.
Cautions Concerning Forward-Looking Statements
This press release contains "forward-looking statements" as
defined in the Private Securities Litigation Reform Act of 1995
regarding the voluntary recall of specific NEUTROGENA®
and AVEENO® aerosol sunscreen products. The reader is
cautioned not to rely on these forward-looking statements. These
statements are based on current expectations of future
events. If underlying assumptions prove inaccurate or known or
unknown risks or uncertainties materialize, actual results could
vary materially from the expectations and projections of Johnson
& Johnson Consumer Inc. and/or Johnson & Johnson.
Risks and uncertainties include, but are not limited to: product
efficacy or safety concerns resulting in product recalls or
regulatory action; significant adverse litigation or
government action, including related to product liability claims;
uncertainty of commercial success for new and existing products;
the ability of the company to successfully execute strategic plans;
manufacturing difficulties or delays, internally or within the
supply chain; changes to applicable laws and regulations; changes
in behavior and spending patterns of purchasers of health care
products and services; and increased scrutiny of the health care
industry by government agencies. A further list and
descriptions of these risks, uncertainties and other factors can be
found in Johnson & Johnson's Annual Report on Form 10-K for the
fiscal year ended January 3, 2021,
including in the sections captioned "Cautionary Note Regarding
Forward-Looking Statements" and "Item 1A. Risk Factors," and in the
company's most recently filed Quarterly Report on Form 10-Q, and
the company's subsequent filings with the Securities and Exchange
Commission. Copies of these filings are available online at
www.sec.gov, www.jnj.com or on request from Johnson & Johnson.
Neither Johnson & Johnson Consumer Inc. nor Johnson &
Johnson undertakes to update any forward-looking statement as a
result of new information or future events or
developments. The Company expressly disclaims all liability in
respect to actions taken or not taken based on any or all the
contents of this press release.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/johnson--johnson-consumer-inc-issues-voluntary-recall-of-specific-neutrogena-and-aveeno-aerosol-sunscreen-products-due-to-the-presence-of-benzene-301334144.html
SOURCE Johnson & Johnson